关注
Diwash Jangam
Diwash Jangam
Life Science Research Professional, Stanford University
在 stanford.edu 的电子邮件经过验证
标题
引用次数
引用次数
年份
Transposable element domestication as an adaptation to evolutionary conflicts
D Jangam, C Feschotte, E Betrán
Trends in Genetics 33 (11), 817-831, 2017
2342017
A comprehensive analysis of RHOA mutation positive and negative angioimmunoblastic T-cell lymphomas by targeted deep sequencing, expression profiling and single cell digital …
A Butzmann, K Sridhar, D Jangam, J Kumar, MK Sahoo, N Shahmarvand, ...
International Journal of Molecular Medicine 46 (4), 1466-1476, 2020
132020
Mutations in JAK/STAT and NOTCH1 Genes Are Enriched in Post-Transplant Lymphoproliferative Disorders
A Butzmann, K Sridhar, D Jangam, H Song, A Singh, J Kumar, ...
Frontiers in Oncology 11, 790481, 2022
122022
Molecular genetic testing methodologies in hematopoietic diseases: current and future methods
K Sridhar, A Singh, A Butzmann, D Jangam, RS Ohgami
International Journal of Laboratory Hematology 41, 102-116, 2019
102019
Longitudinal study of 2 patients with cyclic thrombocytopenia, STAT3 and MPL mutations
H Zhang, M Chien, Y Hou, W Shomali, RS Brar, C Ho, P Han, D Xu, ...
Blood Advances 7 (1), 190-194, 2023
82023
TBL1XR1 Mutations in Primary Marginal Zone Lymphomas of Ocular Adnexa are Associated with Unique Morphometric Phenotypes
D Jangam, K Sridhar, A Butzmann, P Samghabadi, ED Plowey, ...
Current Eye Research 45 (12), 1583-1589, 2020
52020
Smoking status in acute myeloid leukemia is associated with worse overall survival and independent of prior nonhematopoietic malignancies, cytogenetic abnormalities, and WHO …
J Kumar, S Patel, A Chang, S Mukherjee, C Small, S Gollapudi, ...
Human Pathology 135, 45-53, 2023
22023
Significance of bacterial and viral genotypes as a risk factor in driving cancer
D Jangam, A Butzmann, K Sridhar, S Deresinski, N Banaei, RS Ohgami
Molecular and clinical oncology 13 (1), 3-12, 2020
22020
Indolent in situ B-cell neoplasms with MYC rearrangements show somatic mutations in MYC and TNFRSF14 by next-generation sequencing
J Kumar, A Butzmann, S Wu, S Easly, JL Zehnder, RA Warnke, CD Bangs, ...
The American Journal of Surgical Pathology 43 (12), 1720-1725, 2019
22019
Impact of Down-Sampling T-Cell Receptor Sequencing Reads on Clonality Interpretation
C Ho, M Zhang, D Jangam, D Wiredja, C Suarez, B Zhang
JOURNAL OF MOLECULAR DIAGNOSTICS 25 (11), S83-S83, 2023
2023
Performance Evaluation of a Next-Generation SequencingBased T-Cell Receptor Gene Rearrangement Assay
D Wiredja, D Libert, D Jangam, C Ho, J Tung, B Zhang
JOURNAL OF MOLECULAR DIAGNOSTICS 25 (11), S141-S142, 2023
2023
Profiling endogenous, environmental, and infectious disease mutational signatures in blastic plasmacytoid dendritic cell neoplasms
C Small, S Mukerjee, D Jangam, S Gollapudi, K Singh, DL Jaye, PP Aung, ...
International Journal of Laboratory Hematology 45 (5), 726-734, 2023
2023
Identification and confirmation via in situ hybridization of Merkel cell polyomavirus in rare cases of posttransplant cutaneous T‐cell lymphoma
L Lawrence, A Wang, G Charville, CL Liu, A Garofalo, A Alizadeh, ...
Journal of Cutaneous Pathology 50 (9), 835-844, 2023
2023
Minimal/Measurable Residual Disease Monitoring in Patients with Lymphoid Neoplasms by High-Throughput Sequencing of the T-Cell Receptor
JK Tung, D Jangam, CC Ho, E Fung, MS Khodadoust, YH Kim, ...
The Journal of Molecular Diagnostics 25 (6), 331-341, 2023
2023
A Case of EBV-Negative Aggressive NK-cell Leukemia: Use of Next-Generation Sequencing in Demystifying a Diagnostic Dilemma and Guiding Clinical Care
VE Kennedy, R Ruiz-Cordero, D Jangam, KW Wen, N Dunavin, ...
Clinical Lymphoma Myeloma and Leukemia 21 (7), e583-e587, 2021
2021
系统目前无法执行此操作,请稍后再试。
文章 1–15